Lemaitre Vascular (LMAT) Operating Leases (2019 - 2026)

Lemaitre Vascular (LMAT) has reported Operating Leases for 8 consecutive years, with $21.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases rose 42.46% year-over-year to $21.2 million in Q2 2026; TTM through Jun 2026 was $21.2 million, a 42.46% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, down 8.07% from the prior year.
• Operating Leases was $21.2 million for Q2 2026 at Lemaitre Vascular, up from $20.9 million in the prior quarter.
• Over five years, Operating Leases peaked at $21.2 million in Q2 2026 and troughed at $14.0 million in Q4 2025.
• A 5-year average of $16.9 million and a median of $16.8 million in 2022 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases fell 21.93% in 2025 and jumped 42.46% in 2026, its largest moves.
• Over 5 years, Operating Leases stood at $14.7 million in 2022, then gained by 13.01% to $16.6 million in 2023, then dropped by 8.37% to $15.2 million in 2024, then declined by 8.07% to $14.0 million in 2025, then jumped by 51.13% to $21.2 million in 2026.
• The last three Operating Leases figures came in at $21.2 million (Q2 2026), $20.9 million (Q1 2026), and $14.0 million (Q4 2025), per Business Quant data.